SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001078782-17-001264
Filing Date
2017-09-14
Accepted
2017-09-14 11:20:01
Documents
59
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10QA AMENDED QUARTERLY REPORT f10qa033117_10qz.htm 10-Q/A 424463
2 EXHIBIT 31.1 SECTION 302 CERTIFICATION f10qa033117_ex31z1.htm EX-31.1 7173
3 EXHIBIT 31.2 SECTION 302 CERTIFICATION f10qa033117_ex31z2.htm EX-31.2 7327
4 EXHIBIT 32.1 SECTION 906 CERTIFICATION f10qa033117_ex32z1.htm EX-32.1 3437
5 EXHIBIT 32.2 SECTION 906 CERTIFICATION f10qa033117_ex32z2.htm EX-32.2 3415
  Complete submission text file 0001078782-17-001264.txt   2360314

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axim-20170331_cal.xml EX-101.CAL 4638
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axim-20170331_def.xml EX-101.DEF 23493
8 XBRL INSTANCE DOCUMENT axim-20170331.xml EX-101.INS 278530
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT axim-20170331_lab.xml EX-101.LAB 273134
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axim-20170331_pre.xml EX-101.PRE 158924
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axim-20170331.xsd EX-101.SCH 66917
Mailing Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022
Business Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-54296 | Film No.: 171084997
SIC: 2834 Pharmaceutical Preparations